August 2017 FDA Recall Drug by Wockhardt Usa Inc.
D-0051-2018 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Wockhardt Usa Inc. on August 22, 2017 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0051-2018

Reason for Recall
Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.
Initiated
08-22-2017
Reported
11-01-2017
Quantity
5050 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide in the USA
Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India, Distributed by: Wockhardt, USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054, USA. NDC: 64679-924-03;

Batch or Lot Expiration Information

Lot# DR10635, EXP 05/2019; DR10636, EXP 05/2019.